Skip to main content
. 2023 Jul 6;20(7):e1004253. doi: 10.1371/journal.pmed.1004253

Table 4. Histological outcomes and number of colposcopies performed per CIN2+/CIN3+ case detected in the intervention and reference groups.

Intervention group Reference group
Eligible women 11,192 33,387
Tested women 6,965 743
Women with adequate histology* 357 75
Worst histology result
<CIN2 313 64
CIN2+** 44 11
CIN3+*** 26 7
Cervical cancer 4 4
CIN2+ cases according to age p-value¤ p-value¤
65–67 (%, [95% CI]) 12 (0.5, [0.2, 0.8]) 0.30 5 (1.6, [0.5, 3.7]) 0.82
68–69 (%, [95% CI]) 32 (0.7, [0.5, 1.0]) 6 (1.4, [0.5, 3.0])
CIN2+ cases according to screening history at age 50–64
Insufficiently screened n (%, [95% CI]) 6 (1.4, [0.5, 2.9]) p = 0.05 3 (4.6, [0.9, 12.9]) p = 0.03
Sufficiently screened n (%, [95% CI]) 38 (0.6,[0.4, 0.8]) 8 (1.2, [0.5, 2.3])
Histology results per 1,000 eligible womena [95% CI] p-value¤¤
<CIN2 28.0 [25.0, 31.1] 1.9 [1.5, 2.5] p < 0.001
CIN2+ 3.9 [2.9, 5.3] 0.3 [0.2, 0.6] p < 0.001
CIN3+ 2.3 [1.5, 3.4] 0.2 [0.1, 0.4] p < 0.001
Cervical cancer 0.4 [0.09, 0.9] 0.1 [0.03, 0.3] p = 0.10
Colposcopies
Number of colposcopies performed 511## 111##
Number of colposcopies performed per CIN2+ case [95% CI] 11.6 [8.5, 15.8] 10.1 [5.4, 18.8] 0.69
Number of colposcopies performed per CIN3+ case [95% CI] 19.6 [13.2,29.2] 15.8 [7.4, 34.0] 0.62

CI, confidence interval. Adequate: women with inadequate or missing histology results were excluded.

* From biopsy, ECC or LEETZ from the worst diagnosis identified during follow-up.

** CIN2+ includes: CIN2, CIN3/AIS, CIN and cancer.

*** CIN3+ includes: CIN3/AIS and cancer.

aUnadjusted for age and screening history at age 50–64.

¤p-Value: comparison within group.

¤¤p-Value: comparison between intervention and reference group.

##Some women had >1 biopsy during follow-up and thus the number of colposcopies performed were higher than the number of women with adequate histology.